$16.32
-0.56-3.32%
At close: -
$16.55
0.231.41%
After Hours: 7:08 PM EDT
Comments
Loading...
Latest Beam Therapeutics Stock News | NASDAQ:BEAM | Benzinga
Get the latest news on Beam Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Beam Therapeutics performance
Categories: All
Thursday, May 29, 2025
Wednesday, May 14, 2025
Monday, May 12, 2025
Wednesday, May 07, 2025
Tuesday, May 06, 2025
Monday, April 21, 2025
Monday, April 07, 2025
Saturday, April 05, 2025
Friday, April 04, 2025
Friday, March 28, 2025
Thursday, March 27, 2025
Saturday, March 22, 2025
Wednesday, March 12, 2025
Monday, March 10, 2025
- Scotiabank Upgrades Beam Therapeutics to Sect...
- Jones Trading Upgrades Beam Therapeutics to B...
- HC Wainwright & Co. Reiterates Buy on Beam Th...
- Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity
- Beam Therapeutics shares are trading lower af...
- Beam Therapeutics Priced Underwritten Offerin...
- Beam Therapeutics Announced Initial Safety An...
